Pages that link to "Q32061315"

The following pages link to Solution Structure and Main Chain Dynamics of the Regulatory Domain (Residues 1–91) of Human Cardiac Troponin C (Q32061315):

Displaying 21 items.

• Calcium induced regulation of skeletal troponin--computational insights from molecular dynamics simulations (Q27335224) (← links)
• Structure of the Inhibitor W7 Bound to the Regulatory Domain of Cardiac Troponin C (Q27655388) (← links)
• The effect of the cosolvent trifluoroethanol on a tryptophan side chain orientation in the hydrophobic core of troponin C (Q27655623) (← links)
• Structural based insights into the role of troponin in cardiac muscle pathophysiology (Q28235083) (← links)
• A new amide proton R1rho experiment permits accurate characterization of microsecond time-scale conformational exchange (Q28276059) (← links)
• Binding of levosimendan, a calcium sensitizer, to cardiac troponin C. (Q30632646) (← links)
• Conformations of the regulatory domain of cardiac troponin C examined by residual dipolar couplings (Q30951999) (← links)
• Ca2 -induced PRE-NMR changes in the troponin complex reveal the possessive nature of the cardiac isoform for its regulatory switch. (Q34506540) (← links)
• The contractile apparatus as a target for drugs against heart failure: interaction of levosimendan, a calcium sensitiser, with cardiac troponin c. (Q36007118) (← links)
• Enhanced troponin I binding explains the functional changes produced by the hypertrophic cardiomyopathy mutation A8V of cardiac troponin C (Q36984342) (← links)
• Biological function and site II Ca2 -induced opening of the regulatory domain of skeletal troponin C are impaired by invariant site I or II Glu mutations (Q42632264) (← links)
• Interaction of bepridil with the cardiac troponin C/troponin I complex (Q43759768) (← links)
• Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice. (Q47237484) (← links)
• Surface exposure of the methionine side chains of calmodulin in solution. A nitroxide spin label and two-dimensional NMR study (Q50147662) (← links)
• Development of computational and graphical tools for analysis of movement and flexibility in large molecules (Q52072966) (← links)
• Conformation of the regulatory domain of cardiac muscle troponin C in its complex with cardiac troponin I. (Q53923220) (← links)
• Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper (Q60950194) (← links)
• Cardiac troponin I inhibitory peptide: location of interaction sites on troponin C (Q73538984) (← links)
• Observation of microsecond time-scale protein dynamics in the presence of Ln3 ions: application to the N-terminal domain of cardiac troponin C (Q79443239) (← links)
• Levosimendan Improves Oxidative Balance in Cardiogenic Shock/Low Cardiac Output Patients (Q89529098) (← links)
• Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use (Q97884755) (← links)